Azerbaijan vs Chad: HIV-positive TB patients on ART (antiretroviral therapy)
Azerbaijan
100.0%
in 2024
Chad
100.0%
in 2024
Azerbaijan rank
1st
Chad rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Azerbaijan
- Chad
How they compare
Azerbaijan currently reports 100.0% against 100.0% in Chad, a difference of 0.0%.
The two have swapped places 5 times across 13 shared years of data; in 2011 it was Azerbaijan ahead.
Azerbaijan ranks 1st and Chad ranks 1st of 144 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Chad in 1.
Head to head by decade
| Decade | Azerbaijan | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.4% | 63.1% | 9.2% | Azerbaijan |
| 2020s | 98.2% | 99.4% | 1.2% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or Chad?
- Azerbaijan, at 100.0% against 100.0% in Chad as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and Chad?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Chad?
- 13 years are reported by both, from 2011 to 2024.
- How do Azerbaijan and Chad rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Azerbaijan ranks 1st and Chad ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.